Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

December 1988

Volume 544 Antifungal Drugs

Pages 1–610

  1. Part I. Design, Synthesis, and Structure- Activity Relationships of Antifungal Agents

    1. Top of page
    2. Part I. Design, Synthesis, and Structure- Activity Relationships of Antifungal Agents
    3. Part I. Design, Synthesis, and Structure-Activity Relationships of Antifungal Agents
    4. Part II. Structural Elucidation, Synthesis, and Antifungal Activity of Natural Products and Related Derivatives
    5. Part III. Biochemical Studies and Mechanism of Action of Antifungal Agents
    6. Part IV. Preclinical Evaluation of Antifungal Agents
    7. Part V. Pharmacokinetics of Antifungal Agents
    8. Part VI. Clinical Evaluation of Antifungal Drugs
    9. Part VII. Drug Delivery Systems of Antifungal Drugs
    1. Design and Evaluation of a Systemically Active Agent, Fluconazole (pages 4–11)

      K. RICHARDSON, K. COOPER, M. S. MARRIOTT, M. H. TARBIT, P. F. TROKE and P. J. WHITTLE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40385.x

    2. Synthesis of Antifungal Imidazoles and Triazoles (pages 12–31)

      MASARU OGATA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40386.x

    3. Synthesis and Antifungal Activity of Novel Isoxazolidine Compounds (pages 32–45)

      GEORGE B. MULLEN, PATRICIA A. SWIFT, GRACE A. BENNETT, THOMAS R. DeCORY, DAVID M. MARYNIAK, PETER G. DORMER and VASSIL ST. GEORGIEV

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40387.x

    4. Vibunazole and Its Enantiomers : Synthesis, Antifungal Activity, and Pharmacokinetics (pages 74–85)

      WOLFGANG RITTER, GRAHAM HOLMWOOD, HANS-JUERGEN AHR, KLAUS DETZER, UDO KRAATZ, MANFRED PLEMPEL, DIETRICH SCHERLING and HANS-MARTIN SIEFERT

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40390.x

    5. Synthesis and Structure-Activity Relationships of a Novel Antifungal Agent, ICI 195,739 (pages 86–100)

      F. THOMAS BOYLE, DAVID J. GILMAN, MICHAEL B. GRAVESTOCK and J. MICHAEL WARDLEWORTH

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40391.x

  2. Part I. Design, Synthesis, and Structure-Activity Relationships of Antifungal Agents

    1. Top of page
    2. Part I. Design, Synthesis, and Structure- Activity Relationships of Antifungal Agents
    3. Part I. Design, Synthesis, and Structure-Activity Relationships of Antifungal Agents
    4. Part II. Structural Elucidation, Synthesis, and Antifungal Activity of Natural Products and Related Derivatives
    5. Part III. Biochemical Studies and Mechanism of Action of Antifungal Agents
    6. Part IV. Preclinical Evaluation of Antifungal Agents
    7. Part V. Pharmacokinetics of Antifungal Agents
    8. Part VI. Clinical Evaluation of Antifungal Drugs
    9. Part VII. Drug Delivery Systems of Antifungal Drugs
    1. Pyrido[3,4=e]-1,2,4=triazines and Related Heterocycles as Potential Antifungal Agents (pages 101–104)

      M. F. REICH, P. F. FABIO, V. J. LEE, N. A. KUCK and R. T. TESTA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40392.x

    2. Synthesis and Antifungal Properties of Dihydrobenzothiophene Azoles (pages 105–108)

      D. F. RANE, J. A. DESAI, D. LOEBENBERG, R. PARMEGIANI and R. E. PIKE

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40393.x

    3. Synthesis and Antifungal Properties of 14-Aminomethyl-Substituted Lanosterol Derivatives (pages 109–112)

      A. B. COOPER, J. J. WRIGHT, A. K. GANGULY, J. DESAI, D. LOEBENBERG, R. PARMEGIANI and D. S. FEINGOLD

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40394.x

  3. Part II. Structural Elucidation, Synthesis, and Antifungal Activity of Natural Products and Related Derivatives

    1. Top of page
    2. Part I. Design, Synthesis, and Structure- Activity Relationships of Antifungal Agents
    3. Part I. Design, Synthesis, and Structure-Activity Relationships of Antifungal Agents
    4. Part II. Structural Elucidation, Synthesis, and Antifungal Activity of Natural Products and Related Derivatives
    5. Part III. Biochemical Studies and Mechanism of Action of Antifungal Agents
    6. Part IV. Preclinical Evaluation of Antifungal Agents
    7. Part V. Pharmacokinetics of Antifungal Agents
    8. Part VI. Clinical Evaluation of Antifungal Drugs
    9. Part VII. Drug Delivery Systems of Antifungal Drugs
    1. Antifungal Substances from Marine Invertebrates (pages 113–127)

      NOBUHIRO FUSETANI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40395.x

    2. The Galbonolides : Novel, Powerful Antifungal Macrolides from Streptomyces galbus ssp. eurythermus (pages 128–140)

      HANS ACHENBACH, ANDREAS MÜHLENFELD, URSULA FAUTH and HANS ZÄHNER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40396.x

    3. Antifungal Proteins from Plants (pages 141–151)

      WALDEN K. ROBERTS, BRIDGET E. LAUE and CLAUDE P. SELITRENNIKOFF

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40397.x

    4. Synthesis and Evaluation of LY121019, a Member of a Series of Semisynthetic Analogues of the Antifungal Lipopeptide Echinocandin B (pages 152–167)

      M. DEBONO, B. J. ABBOTT, J. R. TURNER, L. C. HOWARD, R. S. GORDEE, A. S. HUNT, M. BARNHART, R. M. MOLLOY, K. E. WILLARD, D. FUKUDA, T. F. BUTLER and D. J. ZECKNER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40398.x

    5. Hydroxamic Acid Antimycotic Antibiotics : A New Group of Antibiotics (pages 180–182)

      YOSHIO INOUYE, HIROMASA OKADA and SHOSHIRO NAKAMURA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40400.x

    6. L-660,631, a New Antifungal Agent (page 183)

      A. J. KEMPF, O. D. HENSENS, R. E. SCHWARTZ, R. S. SYKES, K. E. WILSON, C. F. WICHMANN, D. L. ZINK, L. ZITANO and S. MOCHALES

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40401.x

    7. Novel Antifungal Antibiotic BMY-28567 : Structural Study and Biological Activities (pages 184–187)

      TOSHIKAZU OKI, KYOICHIRO SAITOH, KOZO TOMATSU, KOJI TOMITA, MASATAKA KONISHI and HIROSHI KAWAGUCHI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40402.x

    8. RI-331, a New Antifungal Antibiotic (pages 188–190)

      HIDEYO YAMAGUCHI, KATSUHISA UCHIDA, TAMIO HIRATANI, TAKATOSHI NAGATE, NAOHARU WATANABE and SADATOSHI OMURA

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40403.x

  4. Part III. Biochemical Studies and Mechanism of Action of Antifungal Agents

    1. Top of page
    2. Part I. Design, Synthesis, and Structure- Activity Relationships of Antifungal Agents
    3. Part I. Design, Synthesis, and Structure-Activity Relationships of Antifungal Agents
    4. Part II. Structural Elucidation, Synthesis, and Antifungal Activity of Natural Products and Related Derivatives
    5. Part III. Biochemical Studies and Mechanism of Action of Antifungal Agents
    6. Part IV. Preclinical Evaluation of Antifungal Agents
    7. Part V. Pharmacokinetics of Antifungal Agents
    8. Part VI. Clinical Evaluation of Antifungal Drugs
    9. Part VII. Drug Delivery Systems of Antifungal Drugs
    1. Mode of Action Studies: Basis for the Search of New Antifungal Drugs (pages 191–207)

      HUGO VANDEN BOSSCHE, PATRICK MARICHAL, JOS GORRENS, HUGO GEERTS and PAUL A. J. JANSSEN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40404.x

    2. Mode of Action of Morpholine Derivatives (pages 221–228)

      ANNEMARIE POLAK

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40406.x

    3. Mode Of Action of L-660,631 in Candida albicans (page 229)

      JANET C. ONISHI, GEORGE K. ABRUZZO, ROBERT A. FROMTLING, GEORGE M. GARRITY, JAMES A. MILLIGAN, BARBARA A. PELAK and WALTER ROZDILSKY

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40407.x

    4. Mode of Action of β-Lactone 1233A in Candida albicans (page 230)

      JANET C. ONISHI, GEORGE K. ABRUZZO, ROBERT A. FROMTLING, GEORGE M. GARRITY, JAMES A. MILLIGAN, BARBARA A. PELAK, WALTER ROZDILSKY and BARBARA WEISSBERGER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40408.x

    5. Biochemical Studies with a Novel Antifungal Agent, ICI 195,739 (pages 231–244)

      KEITH BARRETT-BEE, JOYCE LEES, PHILIP PINDER, JULIE CAMPBELL and LORRAINE NEWBOULT

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40409.x

    6. Drug Resistance in Candida albicans and Candida glabrata (pages 245–259)

      DAVID KERRIDGE, MARCO FASOLI and FRANCES J. WAYMAN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40410.x

  5. Part IV. Preclinical Evaluation of Antifungal Agents

    1. Top of page
    2. Part I. Design, Synthesis, and Structure- Activity Relationships of Antifungal Agents
    3. Part I. Design, Synthesis, and Structure-Activity Relationships of Antifungal Agents
    4. Part II. Structural Elucidation, Synthesis, and Antifungal Activity of Natural Products and Related Derivatives
    5. Part III. Biochemical Studies and Mechanism of Action of Antifungal Agents
    6. Part IV. Preclinical Evaluation of Antifungal Agents
    7. Part V. Pharmacokinetics of Antifungal Agents
    8. Part VI. Clinical Evaluation of Antifungal Drugs
    9. Part VII. Drug Delivery Systems of Antifungal Drugs
    1. Role of Animal and Human Pharmacology in Antifungal Drug Design (pages 264–269)

      GEERT CAUWENBERGH and JAN VAN CUTSEM

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40412.x

    2. Use of Chemiluminescence to Evaluate the Influence of Antifungal Agents on Immune Cell Function (pages 270–283)

      ROBERT A. FROMTLING, GEORGE K. ABRUZZO, TRACY A. TURNBULL, DAVID M. GILTINAN and THOMAS P. CAPIZZI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40413.x

    3. In Vitro Potency and in Vivo Activity of Azoles (pages 284–293)

      PETER F. TROKE, MICHAEL S. MARRIOTT, KENNETH RICHARDSON and MICHAEL H. TARBIT

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40414.x

    4. Anti-Candida Activity and Toxicology of LY121019, a Novel Semisynthetic Polypeptide Antifungal Antibiotic (pages 294–309)

      ROBERT S. GORDEE, DOUGLAS J. ZECKNER, LEONARD C. HOWARD, WILLIAM E. ALBORN JR. and MANUEL DEBONO

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40415.x

    5. Activity of ICI 195,739—a Novel, Orally Active Bistriazole—in Rodent Models of Fungal and Protozoal Infections (pages 310–328)

      JOHN F. RYLEY, SANDRA McGREGOR and ROBERT G. WILSON

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40416.x

    6. Sterol Biosynthesis Inhibitors : Secondary Effects and Enhanced in Vivo Efficacy (pages 338–347)

      DIETER BERG, MANFRED PLEMPEL, KARL-HEINZ BÜCHEL, GRAHAM HOLMWOOD and KLAUS STROECH

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40418.x

    7. Direct Fungicidal Action of Tioconazole (pages 354–356)

      WILLIAM H. BEGGS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40420.x

    8. Synergistic Effects of Ketoconazole and SF-86327 on the Proliferation of Epimastigotes and Amastigotes of Trypanosoma (Schizotrypanum) Cruzi (pages 357–358)

      JULIO A. URBINA, KEYLA LAZARDI, GISELA LARRALDE, TANIA AGUIRRE, MARTA M. PIRAS and ROMANO PIRAS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40421.x

    9. Substituted 5-Phenoxyalkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines : Antifungal Activity and Structure-Activity Relationship Studies (pages 359–362)

      GEORGE B. MULLEN, DAVID M. MARYNIAK, PATRICIA A. SWIFT, STANLEY D. ALLEN, JEFFREY T. MITCHELL, C. RICHARD KINSOLVING and VASSIL ST. GEORGIEV

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40422.x

    10. In Vitro Antifungal Activity of Novel Substituted 3,5-Diphenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidine Derivatives (pages 363–365)

      THOMAS R. DeCORY,b, GEORGE B. MULLEN, JEFFREY T. MITCHELL, STANLEY D. ALLEN, C. RICHARD KINSOLVING and VASSIL ST. GEORGIEV

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40423.x

    11. cis-3-(Substituted phenyl)-3-(1H-imidazol-1-ylmethyl)-2-methyl-5-{[(substituted phenyl)thio(or amino)]methyl} isoxazolidines : In Vitro Antifungal Activity and Structure-Activity Relationships (pages 366–368)

      THOMAS R. DeCORY,b, PATRICIA A. SWIFT, GEORGE B. MULLEN, JEFFREY T. MITCHELL, STANLEY D. ALLEN, C. RICHARD KINSOLVING and VASSIL ST. GEORGIEV

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40424.x

    12. 3-(Substituted phenyl)-3-(1H-1,2,4-triazol-1-ylmethyl)-2-methyl-5-[(substituted phenoxy)methyl]-isoxazolidine Derivatives : Structure-Activity Relationships (pages 369–372)

      GRACE A. BENNETT, PATRICIA A. SWIFT, GEORGE B. MULLEN, STANLEY D. ALLEN, JEFFREY T. MITCHELL, C. RICHARD KINSOLVING and VASSIL ST. GEORGIEV

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40425.x

    13. cis-5-Alkoxyalkyl-3-phenyl-3-(1H-imidazol-1- ylmethyl)-2-methylisoxazolidine Derivatives (pages 373–374)

      DAVID M. MARYNIAK, GEORGE B. MULLEN, JEFFREY T. MITCHELL, STANLEY D. ALLEN, C. RICHARD KINSOLVING and VASSIL ST. GEORGIEV

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40426.x

    14. In Vitro Antifungal Activity of Novel Substituted 3,5-Diphenyl-3-(1H-1,2,4-triazol-1-ylmethyl)-2-methylisoxazolidine Derivatives (pages 375–377)

      GRACE A. BENNETT, PATRICIA A. SWIFT, GEORGE B. MULLEN, JEFFREY T. MITCHELL, STANLEY D. ALLEN, C. RICHARD KINSOLVING and VASSIL ST. GEORGIEV

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40427.x

    15. In Vitro Antifungal Activity and Structure-Activity Relationship Studies of Novel cis-5-Acyloxyalkyl-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidine Derivatives (pages 378–380)

      DAVID M. MARYNIAK, GEORGE B. MULLEN, STANLEY D. ALLEN, JEFFREY T. MITCHELL, C. RICHARD KINSOLVING and VASSIL ST. GEORGIEV

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40428.x

    16. cis-5-Alkyl(or alkenyl)-3-phenyl-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidine Derivatives : In Vitro Antifungal Activity and Structure-Activity Relationships (pages 381–383)

      PATRICIA A. SWIFT, GRACE A. BENNETT, GEORGE B. MULLEN, JEFFREY T. MITCHELL, STANLEY D. ALLEN, C. RICHARD KINSOLVING and VASSIL ST. GEORGIEV

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40429.x

    17. Novel 5-Phenyl(or phenoxyalkyl)-3-(2-furanyl)-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines : In Vitro Antifungal Activity (pages 384–386)

      GRACE A. BENNETT, GEORGE B. MULLEN, JEFFREY T. MITCHELL, STANLEY D. ALLEN, C. RICHARD KINSOLVING and VASSIL ST. GEORGIEV

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40430.x

    18. Comparisons of Ketoconazole, PR 969-566, PR 967-234, and PR 967-248 as Antifungals in Vitro and in the Rat Model of Candidal Vaginitis based on Efficacy/Safety Profiles (pages 387–391)

      GENE C. PALMER, J. MARK ORDY, ROY D. SIMMONS, JAMES C. STRAND, GEORGE B. MULLEN, C. RICHARD KINSOLVING, VASSIL ST. GEORGIEV and STANLEY D. ALLEN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40431.x

    19. In Vitro Activity of Novel 5(Phenyl or phenoxyalkyl)-3-(2-thienyl)-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidines (pages 392–395)

      GEORGE B. MULLEN, JEFFREY T. MITCHELL, STANLEY D. ALLEN and VASSIL ST. GEORGIEV

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40432.x

    20. In Vitro Activity of Novel 5-Carbonyl Derivatives of 3-Phenyl-3-(1H-imidazol-1-ylmethyl)-2-methyl-isoxazolidines (pages 396–399)

      GRACE A. BENNETT, GEORGE B. MULLEN, THOMAS R. DeCORY,b, STANLEY D. ALLEN, JEFFREY T. MITCHELL and VASSIL ST. GEORGIEV

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40433.x

    21. In Vitro Activity of Novel cis-5-Substituted-3-(2-naphthalenyl)-3-(1H-imidazol-1-ylmethyl)-2-methylisoxazolidine Derivatives (pages 400–402)

      GRACE A. BENNETT, GEORGE B. MULLEN, STANLEY D. ALLEN, JEFFREY T. MITCHELL and VASSIL ST. GEORGIEV

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40434.x

    22. Antifungal Chemotherapy with Oral Amphotericin B (pages 406–408)

      HIDEYO YAMAGUCHI, KATSUHISA UCHIDA, AKIO URABE and FUMIMARO TAKAKU

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40436.x

    23. Interferon Protects Mice against an Extracellular Infection of Aspergillus fumigatus (pages 409–411)

      R. N. TANDON, A.-R. FEUILLETTE, G. MAHOUY, G. BADILLET, R. M. FRIEDMAN and R. K. MAHESHWARI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40437.x

    24. Inhibition of Candida Species with a Eugenol-Thymol Iodide Mixture (pages 412–413)

      WILLIAM R. HODGE and CIPRIANO RODAS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40438.x

  6. Part V. Pharmacokinetics of Antifungal Agents

    1. Top of page
    2. Part I. Design, Synthesis, and Structure- Activity Relationships of Antifungal Agents
    3. Part I. Design, Synthesis, and Structure-Activity Relationships of Antifungal Agents
    4. Part II. Structural Elucidation, Synthesis, and Antifungal Activity of Natural Products and Related Derivatives
    5. Part III. Biochemical Studies and Mechanism of Action of Antifungal Agents
    6. Part IV. Preclinical Evaluation of Antifungal Agents
    7. Part V. Pharmacokinetics of Antifungal Agents
    8. Part VI. Clinical Evaluation of Antifungal Drugs
    9. Part VII. Drug Delivery Systems of Antifungal Drugs
    1. Steady State Parenteral Kinetics of Fluconazole in Man (pages 427–430)

      G. FOULDS, C. WAJSZCZUK, D. J. WEIDLER, D. J. GARG and P. GIBSON

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40440.x

  7. Part VI. Clinical Evaluation of Antifungal Drugs

    1. Top of page
    2. Part I. Design, Synthesis, and Structure- Activity Relationships of Antifungal Agents
    3. Part I. Design, Synthesis, and Structure-Activity Relationships of Antifungal Agents
    4. Part II. Structural Elucidation, Synthesis, and Antifungal Activity of Natural Products and Related Derivatives
    5. Part III. Biochemical Studies and Mechanism of Action of Antifungal Agents
    6. Part IV. Preclinical Evaluation of Antifungal Agents
    7. Part V. Pharmacokinetics of Antifungal Agents
    8. Part VI. Clinical Evaluation of Antifungal Drugs
    9. Part VII. Drug Delivery Systems of Antifungal Drugs
    1. Fungal Infections in Cancer Patients (pages 431–442)

      GERALD P. BODEY

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40441.x

    2. Treatment of Mycoses with Itraconazole (pages 451–470)

      RICHARD M. TUCKER, PAUL L. WILLIAMS, EDUARDO G. ARATHOON and DAVID A. STEVENS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40443.x

    3. Chronic Mucocutaneous Candidiasis : Antibiotic and Immunologic Therapy (pages 471–480)

      CHARLES H. KIRKPATRICK

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40444.x

    4. Treatment of Coccidioidomycosis (pages 481–487)

      JOHN R. GRAYBILL

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40445.x

    5. Ketoconazole Treatment of Coccidioidal Meningitis (pages 488–496)

      JOHN R. GRAYBILL, DAVID A. STEVENS, JOHN N. GALGIANI, ALAN M. SUGAR, PHILIP C. CRAVEN, CLARK GREGG, MILTON HUPPERT, GRETCHEN CLOUD and WILLIAM E. DISMUKES

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40446.x

    6. Azole Derivatives in the Treatment of Paracoccidioidomycosis (pages 497–503)

      RICARDO NEGRONI

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40447.x

    7. Treatment of Chromoblastomycosis with Itraconazole (pages 504–516)

      ANGELA RESTREPO, AURELIO GONZALEZ, IVAN GOMEZ, MYRTHA ARANGO and CATALINA DE BEDOUT

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40448.x

    8. Treatment of Fungal Infections with Semisynthetic Derivatives of Amphotericin B (pages 517–546)

      PAUL D. HOEPRICH, NEIL M. FLYNN, MILDRED M. KAWACHI, KENNETH K. LEE, RUTH M. LAWRENCE, LARRY K. HEATH and CARL P. SCHAFFNER

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40449.x

    9. Pathogenesis and Epidemiology of Vulvovaginal Candidiasis (pages 547–557)

      JACK D. SOBEL

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40450.x

    10. Prophylactic Use of Clotrimazole in Recurrent Vaginal Candidosis (pages 558–560)

      T. E. C. BUSHELL, E. G. V. EVANS, P. A. LLEWELLYN, J. D. MEADEN, J. D. MILNE and D. W. WARNOCK

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40451.x

    11. Single-Dose Oral Fluconazole in the Treatment of Vaginal Candidosis (pages 561–563)

      KEITH W. BRAMMER and JOSEPH M. FECZKO

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40452.x

    12. Fluconazole for the Treatment of Fungal Diseases in Immunosuppressed Patients (pages 564–570)

      B. DUPONT and E. DROUHET

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40453.x

    13. Parenteral 5-Fluorocytosine in the Therapy of Systemic Mycoses (pages 571–574)

      FRANCIS A. MINA, SCOTT J. HOPKINS and BONNIE RICHELO

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40454.x

    14. Serodiagnosis of Invasive Candidiasis (pages 575–579)

      LOWELL S. YOUNG and PAUL R. STEVENS

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40455.x

    15. New Oral Treatments for Dermatophytosis (pages 580–585)

      RODERICK J. HAY

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40456.x

    16. Topical Treatment of Onychomycosis Using Bifonazole 1% Urea/40% Paste (pages 586–587)

      D. T. ROBERTS, R. J. HAY, V. R. DOHERTY, M. D. RICHARDSON and Y. M. CLAYTON

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40457.x

    17. Correlations between Two-Feet-One-Hand Dermatophytosis, Palmar Sweating, and Handedness (pages 588–589)

      S. BENDER, M. WILSON and Y. LYNFIELD

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40458.x

  8. Part VII. Drug Delivery Systems of Antifungal Drugs

    1. Top of page
    2. Part I. Design, Synthesis, and Structure- Activity Relationships of Antifungal Agents
    3. Part I. Design, Synthesis, and Structure-Activity Relationships of Antifungal Agents
    4. Part II. Structural Elucidation, Synthesis, and Antifungal Activity of Natural Products and Related Derivatives
    5. Part III. Biochemical Studies and Mechanism of Action of Antifungal Agents
    6. Part IV. Preclinical Evaluation of Antifungal Agents
    7. Part V. Pharmacokinetics of Antifungal Agents
    8. Part VI. Clinical Evaluation of Antifungal Drugs
    9. Part VII. Drug Delivery Systems of Antifungal Drugs
    1. Liposomes as Carriers of Antifungal Drugs (pages 590–597)

      GABRIEL LOPEZ-BERESTEIN

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40459.x

    2. Amphotericin B Encapsulated in Liposomes Administered to Cancer Patients (pages 598–610)

      F. MEUNIER, J. P. SCULIER, A. COUNE, C. BRASSINNE, C. HEYMAN, C. LADURON, N. COLLETTE, C. HOLLAERT, D. BRON and J. KLASTERSKY

      Version of Record online: 17 DEC 2006 | DOI: 10.1111/j.1749-6632.1988.tb40460.x

SEARCH

SEARCH BY CITATION